haloperidol and ngd 94-1
haloperidol has been researched along with ngd 94-1 in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, X; Donovan, H; He, XS; Hoffman, DC; Hutchison, A; Jones-Hertzog, DK; Meade, R; Thurkauf, A; Wasley, JW; Woodruff, KH; Yuan, J | 1 |
Hopkins, CR; Lindsley, CW | 1 |
Elsworth, JD; Jentsch, JD; Redmond, DE; Roth, RH; Taylor, JR; Youngren, KD | 1 |
Reviews
1 review(s) available for haloperidol and ngd 94-1
Article | Year |
---|---|
Return of D
Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders | 2017 |
Other Studies
2 other study(ies) available for haloperidol and ngd 94-1
Article | Year |
---|---|
2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.
Topics: Antipsychotic Agents; Clozapine; Dopamine D2 Receptor Antagonists; Humans; Receptors, Dopamine D4 | 1997 |
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
Topics: Animals; Chlorocebus aethiops; Cognition Disorders; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Hallucinogens; Haloperidol; Imidazoles; Male; Phencyclidine; Prefrontal Cortex; Pyrimidines; Receptors, Dopamine D4 | 1999 |